ImmunoGen (IMGN) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

ImmunoGen (IMGN) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: June 8, 2023 (08:17)

Sector: Healthcare

The share price of ImmunoGen, Inc. (IMGN) now

What analysts predict: $14.96
52-week High/Low: $15.59 / $3.1

50/200 Day Moving Average: $8.34 / $5.84

This figure corresponds to the Average Price over the previous 50/200 days. For ImmunoGen stocks, the 50-day moving average is the support level today.

For ImmunoGen stocks, the 200-day moving average is the support level today.

Are you interested in ImmunoGen, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ImmunoGen stock price in 2023, 2024, 2025, 2026, 2027. How much will one ImmunoGen share be worth in 2023 - 2027?

When should I take profit in ImmunoGen stock? When should I record a loss on ImmunoGen stock? What are analysts' forecasts for ImmunoGen stock? What is the future of ImmunoGen stock? We forecast ImmunoGen stock performance using neural networks based on historical data on ImmunoGen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

ImmunoGen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ImmunoGen shares. This happens once a day.




Historical and forecast chart of ImmunoGen stock

The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below.

Long-term forecasts by years.

ImmunoGen daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 10 14.55 14.46 14.82 2.45
Jun 11 14.49 14.41 14.76 2.45
Jun 12 14.32 14.10 14.54 3.13
Jun 13 14.04 13.87 14.25 2.77
Jun 14 14.28 14.14 14.36 1.58
Jun 15 14.40 14.14 14.63 3.51
Jun 16 14.36 14.12 14.58 3.30
Jun 17 14.51 14.26 14.71 3.14
Jun 18 14.72 14.60 14.95 2.46
Jun 19 14.63 14.41 14.81 2.83
Jun 20 14.66 14.57 14.91 2.29
Jun 21 14.89 14.70 15.05 2.37
Jun 22 14.83 14.60 14.90 2.08
Jun 23 14.98 14.91 15.10 1.27
Jun 24 14.84 14.64 15.07 2.94
Jun 25 15.00 14.78 15.27 3.34
Jun 26 14.99 14.83 15.23 2.70
Jun 27 15.18 14.91 15.37 3.14
Jun 28 15.17 15.05 15.44 2.62
Jun 29 14.89 14.79 15.00 1.44
Jun 30 14.78 14.59 15.00 2.84
Jul 01 14.44 14.34 14.55 1.41
Jul 02 14.51 14.32 14.60 1.96
Jul 03 14.36 14.11 14.56 3.23
Jul 04 14.37 14.24 14.63 2.71
Jul 05 14.66 14.39 14.86 3.23
Jul 06 14.69 14.51 14.87 2.49
Jul 07 14.54 14.38 14.74 2.44
Jul 08 14.52 14.31 14.69 2.61
Jul 09 14.69 14.55 14.78 1.60

ImmunoGen Daily Price Targets


ImmunoGen Stock Forecast 06-10-2023.

Forecast target price for 06-10-2023: $14.55.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.395%.
Pessimistic target level: 14.46
Optimistic target level: 14.82

ImmunoGen Stock Forecast 06-11-2023.

Forecast target price for 06-11-2023: $14.49.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.394%.
Pessimistic target level: 14.41
Optimistic target level: 14.76

ImmunoGen Stock Forecast 06-12-2023.

Forecast target price for 06-12-2023: $14.32.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 3.036%.
Pessimistic target level: 14.10
Optimistic target level: 14.54

ImmunoGen Stock Forecast 06-13-2023.

Forecast target price for 06-13-2023: $14.04.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.697%.
Pessimistic target level: 13.87
Optimistic target level: 14.25

ImmunoGen Stock Forecast 06-14-2023.

Forecast target price for 06-14-2023: $14.28.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 1.555%.
Pessimistic target level: 14.14
Optimistic target level: 14.36

ImmunoGen Stock Forecast 06-15-2023.

Forecast target price for 06-15-2023: $14.40.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 3.395%.
Pessimistic target level: 14.14
Optimistic target level: 14.63

IMGN (IMGN) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jul. 16.48 15.12 17.51 13.69
Aug. 16.87 16.04 18.26 12.19
Sep. 17.38 16.75 19.15 12.52
Oct. 16.99 15.87 19.00 16.50
Nov. 17.80 16.71 18.95 11.84
Dec. 17.80 16.73 19.24 13.04

ImmunoGen forecast for this year


ImmunoGen Stock Prediction for Jul 2023

An uptrend is forecast for this month with an optimal target price of $16.4766. Pessimistic: $15.12. Optimistic: $17.51


ImmunoGen Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $16.8721. Pessimistic: $16.04. Optimistic: $18.26


ImmunoGen Stock Prediction for Sep 2023

An uptrend is forecast for this month with an optimal target price of $17.3782. Pessimistic: $16.75. Optimistic: $19.15


ImmunoGen Stock Prediction for Oct 2023

An downtrend is forecast for this month with an optimal target price of $16.9872. Pessimistic: $15.87. Optimistic: $19.00


ImmunoGen Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $17.8026. Pessimistic: $16.71. Optimistic: $18.95


ImmunoGen Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $17.8026. Pessimistic: $16.73. Optimistic: $19.24



ImmunoGen (IMGN) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 19.03 16.89 19.66 14.09
Feb 20.20 18.69 22.47 16.85
Mar 20.05 17.91 20.80 13.88
Apr 23.00 22.31 23.72 5.96
May 21.69 20.13 23.15 13.07
Jun 21.65 20.91 23.34 10.44
Jul 20.81 19.87 22.43 11.41
Aug 22.49 19.80 23.34 15.18
Sep 22.73 20.11 24.61 18.29
Oct 22.70 20.08 24.13 16.79
Nov 25.90 24.11 28.07 14.11
Dec 27.02 25.12 28.93 13.17

ImmunoGen (IMGN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 30.15 29.06 32.59 10.82
Feb 25.76 24.41 27.42 10.99
Mar 23.90 21.32 26.09 18.28
Apr 23.44 21.93 25.06 12.49
May 24.81 23.51 27.19 13.55
Jun 25.22 24.01 26.09 7.97
Jul 28.28 25.44 29.56 13.92
Aug 31.89 28.25 34.66 18.49
Sep 34.71 33.15 38.46 13.81
Oct 34.92 33.19 38.06 12.80
Nov 35.97 31.92 38.77 17.67
Dec 32.41 30.27 35.95 15.82

ImmunoGen (IMGN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 34.69 31.41 37.55 16.35
Feb 32.30 30.41 34.09 10.80
Mar 36.95 33.57 40.27 16.65
Apr 36.28 34.21 37.64 9.11
May 33.56 31.90 37.49 14.91
Jun 32.35 31.38 35.90 12.57
Jul 32.69 29.31 35.68 17.87
Aug 36.91 35.75 40.95 12.71
Sep 38.02 33.68 39.27 14.23
Oct 35.05 32.53 36.37 10.55
Nov 31.37 28.45 32.55 12.58
Dec 33.35 32.15 36.10 10.95

ImmunoGen (IMGN) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 33.35 31.30 34.85 10.19
Feb 38.15 36.95 40.04 7.72
Mar 41.30 37.58 44.83 16.17
Apr 42.10 39.58 45.83 13.64
May 44.76 41.00 48.58 15.61
Jun 51.20 48.82 53.12 8.10
Jul 48.74 45.82 53.06 13.64
Aug 50.86 46.59 56.28 17.22
Sep 53.15 50.36 54.99 8.41
Oct 48.37 43.51 50.33 13.55
Nov 49.67 44.38 54.59 18.70
Dec 46.47 42.64 50.51 15.59

ImmunoGen information and performance

ImmunoGen, Inc., a clinical-stage biotechnology company, is developing antibody-drug conjugate (ADC) therapies for cancer. Its candidate products include mirvetuximab soravtansine, an alpha-folate receptor-targeted ADC that is in phase III clinical trials for the treatment of platinum-resistant ovarian cancer; and IMGN632, an ADC targeting CD123, which is in phase I clinical trials for the treatment of AML and blast plasmacytoid dendritic cell neoplasms.

ImmunoGen Address

830 WINTER ST, WALTHAM, MA, US

Market Capitalization: 3 248 626 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -238 676 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.99

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 4.078
Quarterly Revenue Growth YOY: 0.31
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 8.87

Enterprise Value (EV) /Revenue

EV To EBITDA: -4.372

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 226070000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.